. 2020 May 13;9(1):1758602. doi: 10.1080/2162402X.2020.1758602
© 2020 Regeneron Pharmaceuticals. Published with license by Taylor & Francis Group, LLC.
This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial License (http://creativecommons.org/licenses/by-nc/4.0/), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
Figure 2.
Majority of tumor-reactive TCRs are clonally expanded.